Plus therapeutics reports second quarter 2022 financial results and business highlights

Completed enrollment of cohort 1 in respect-lm phase 1/2a dose escalation trial of 186 rnl for leptomeningeal metastases

pstv Ratings Summary

pstv Quant Ranking